Ark Genomic Revolution ETF (ARKG.US) Stock Community - Hot Topic Discussions - Longbridge

For Institutions
- Corporate Services
- Developers
Download
Help
About

Markets

Information

Affiliate Program

Promotions

EN

English

简体中文

繁體中文

繁體中文（廣東話）Posts & comments will be shown in Cantonese

Search...

Quote List Quote List

© 2025 Longbridge｜Disclaimer

Schedules & Filings

Schedules

Filings

Dec31

Distribution Plan(EST)

Cash dividend 0.3823 USD

Dec30

Distribution Plan(EST)

Cash dividend 0.3823 USD

Dec29

Distribution Plan(EST)

Cash dividend 0.3823 USD

View More

Event Tracking

Dec25

ARK Investment by Cathie Wood Buys Shares of WeRide and CRISPR Therapeutics

03:51

Dec24

Evercore ISI Maintains Buy Rating for Beam Therapeutics

11:51

Dec23

CRISPR Therapeutics AG CFO reports sale of company common stock

22:34

Needham Maintains Buy Rating on CRISPR Therapeutics

14:57

Mizuho Maintains Outperform Rating on Guardant Health and Raises Price Target

03:32

Natera Inc. Director Jonathan Sheena Reports Disposition of Common Stock

01:05